Tear Exo
Hyogo
About Tear Exo
Tear Exo is a biotechnology research company. The company is researching cancer detection methods using tears. Tear Exo is creating a health revolution that brings hope and comfort to everyone. A revolution that challenges conventional wisdom.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $352.7K
- Last round: Corporate Round (May 2025)
- Website: tearexo.jp
Industries & Categories
Biotechnology, Health Care, Manufacturing, Product Research, Sales
Canonical: https://fsome.com/organization/tear-exo-17028 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.